The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cytokines in Inflammatory Bowel Disease
Abstract
Cytokines play a central role in the modulation of the intestinal immune system. They are produced by lymphocytes (especially T cells of the Th1 and Th2 phenotypes), monocytes, intestinal macrophages, granulocytes, epithelial cells, endothelial cells, and fibroblasts. They have proinflammatory functions [interleukin‐1 (IL‐1), tumor necrosis factor (TNF), IL‐6, IL‐8, IL‐12] or antiinflammatory functions [interleukin‐1 receptor antagonist (IL‐1ra), IL‐4, IL‐10, IL‐11, transforming growth factor β (TGFβ)]. Mucosal and systemic concentrations of many pro‐ and antiinflammatory cytokines are elevated in inflammatory bowel disease (IBD). An imbalance between proinflammatory and antiinflammatory cytokines was found for the IL‐1/IL‐1ra ratio in the inflamed mucosa of patients with Crohn's disease, ulcerative colitis, diverticulitis, and infectious colitis. Furthermore, the inhibition of proinflammatory cytokines and the supplementations with antiinflammatory cytokines reduced inflammation in animal models, such as the dextran sulfate colitis (DSS) model, the trinitrobenzene sulfonic acid (TNBS) model, or the genetically engineered model of IL‐10 knockout mice. Based on these findings a rationale for cytokine treatment was defined. The first clinical trials using neutralizing monoclonal antibodies against TNFα (cA2) or the antiinflammatory cytokine IL‐10 have shown promising results. However, many questions must be answered before cytokines can be considered standard therapy for IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,272
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
The interleukin‐1 family: 10 years of discovery 1
Dinarello, C. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.15.8001745 · Cited by 783
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.
Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.251 · Cited by 777
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
Braegger, C. P., Nicholls, S., Murch, S. H., MacDonald, T. T., & Stephens, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)90999-j · Cited by 683
Paul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara, R. M., Leary, A. C., Sibley, B., Clark, S. C., & Williams, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7512 · Cited by 652
Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10
O'garra, A., Chang, R., Go, N., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 526
Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M., & Palladino, M. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.2.571 · Cited by 447
Echtenacher, B., Falk, W., Männel, D. N., & Krammer, P. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3762 · Cited by 433
Casini-Raggi, V, Kam, L., Chong, Y. J. T., Fiocchi, C., Pizarro, T. T., & Cominelli, F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2434 · Cited by 407
Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.
Ligumsky, M., Simon, P. L., Karmeli, F., & Rachmilewitz, D. (1990) · Gut · doi:10.1136/gut.31.6.686 · Cited by 400
Niessner, M., & Volk, B. A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03130.x · Cited by 388
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
Schreiber, S., Heinig, T., Thiele, H.-G., & Raedler, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90692-4 · Cited by 372
Duchmann, R., Schmitt, E., Knolle, P., Zum Büschenfelde, K. M., & Neurath, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260432 · Cited by 345
Cominelli, F., Nast, C. C., Clark, B. D., Schindler, R., Lierena, R., Eysselein, V. E., Thompson, R. C., & Dinarello, C. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114799 · Cited by 333
Breese, E. J., Braegger, C., Corrigan, C. J., Walker-Smith, J. A., & MacDonald, T. T. (1993) · PubMed Central · Cited by 327
KOJOUHAROFF, G., HANS, W., OBERMEIER, F., MA¨NNEL, D. N., ANDUS, T., SCHO¨LMERICH, J., GROSS, V, & FALK, W. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1997.291-ce1184.x · Cited by 317
Self-citationIsaacs, K. L., Sartor, R. B., & Haskill, S. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91182-4 · Cited by 314
Sher, A., Fiorentino, D., Caspar, P., Pearce, E., & Mosmann, T. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2713 · Cited by 308
Tumour-necrosis-factor antibody treatment in Crohn's disease
Derkx, B., Taminiau, J., Radema, S., Stronkhorst, A., Wortel, C., Tytgat, G., & van Deventer, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91375-v · Cited by 308
Crawford, R. M., Finbloom, D. S., Ohara, J., Paul, W. E., & Meltzer, M. S. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.1.135 · Cited by 300
Czarniecki, C. W., Chiu, H. H., Wong, G. H. W., McCabe, S. M., & Palladino, M. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4217 · Cited by 294
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Self-citationIncreased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig, R., Andus, T., Aschenbrenner, E., Falk, W., Schölmerich, J., & Gross, V (1996) · Gut · doi:10.1136/gut.38.2.216 · Cited by 291
Self-citationMazzucchelli, L., Hauser, C. J., Z’graggen, K., Wagner, H., Hess, M. W., Laissue, J. A., & Mueller, C. (1994) · PubMed Central · Cited by 286
Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., & Duclos, B. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01540912 · Cited by 281
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease
MITSUYAMA, K., TOYONAGA, A., SASAKI, E., WATANABE, K., TATEISHI, H., NISHIYAMA, T., SAIKI, T., IKEDA, H., TSURUTA, O., & TANIKAWA, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06047.x · Cited by 236
A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease
Sandborn, W. J. (1995) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780010107 · Cited by 217
Mullin, G. E., Lazenby, A. J., Harris, M. L., Bayless, T. M., & James, S. P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91722-g · Cited by 207
Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis
Mahida, Y. R., Ceska, M., Effenberger, F., Kurlak, L., Lindley, I., & Hawkey, C. J. (1992) · Clinical Science · doi:10.1042/cs0820273 · Cited by 199
Youngman, K. R., Simon, P. L., West, G. A., Cominelli, F., Rachmilewitz, D., Klein, J. S., & Fiocchi, C. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91010-f · Cited by 198
Mahida, Y. R., Kurlac, L., Gallagher, A., & Hawkey, C. J. (1991) · Gut · doi:10.1136/gut.32.12.1531 · Cited by 184
Jacobs, C. A., Baker, P. E., Roux, E. R., Picha, K. S., Toivola, B., Waugh, S., & Kennedy, M. K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.2983 · Cited by 181
Fais, S., Capobianchi, M. R., Pallone, F., Di Marco, P., Boirivant, M., Dianzani, F., & Torsoli, A. (1991) · Gut · doi:10.1136/gut.32.4.403 · Cited by 166
Inhibition of human macrophage colony formation by interleukin 4.
Jansen, J. H., Wientjens, G. J., Fibbe, W. E., Willemze, R., & Kluin-Nelemans, H. C. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.577 · Cited by 165
Brynskov, J., Tvede, N., Andersen, C. B., & Vilien, M. (1992) · Gut · doi:10.1136/gut.33.1.55 · Cited by 164
Du, X., Doerschuk, C., Orazi, A., & Williams, D. (1994) · Blood · doi:10.1182/blood.v83.1.33.33 · Cited by 162
Kusugami, K., Fukatsu, A., Tanimoto, M., Shinoda, M., Haruta, J.-I., Kuroiwa, A., Ina, K., Kanayama, K., Ando, T., Matsuura, T., et al. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064182 · Cited by 151
Loetscher, H., Gentz, R., Zulauf, M., Lustig, A., Tabuchi, H., Schlaeǵer, E.-J., Brockhaus, M., Gallati, H., Manneberg, M., & Lesslauer, W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55273-x · Cited by 148
T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice.
Ma, A. I., Datta, M., Margosian, E., Chen, J., & Horak, I. D. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1567 · Cited by 147
Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity
West, G., Matsuura, T., Levine, A., Klein, J., & Fiocchi, C. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964392 · Cited by 135
Cytokine secretion patterns and cross-regulation of T cell subsets
Mosmann, T. R. (1991) · Immunologic Research · doi:10.1007/bf02919690 · Cited by 124
Interleukin 2 Activity of Human Intestinal Mucosa Mononuclear Cells
Fiocchi, C., Hilfiker, M. L., Youngman, K. R., Doerder, N. C., & Finke, J. H. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80124-9 · Cited by 122
Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta.
Welch, G. R., Wong, H. L., & Wahl, S. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3444 · Cited by 121
Geiger, T. M., Towbin, H., Cosenti-Vargas, A., et al. (1994) · PubMed · Cited by 105
Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease
Schreiber, S., Heinig, T., Panzer, U., Reinking, R. R., Bouchard, A., Stahl, P. D., & Raedler, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90004-7 · Cited by 101
Involvement of interleukin-4 and -10 in inflammatory bowel disease
Nielsen, O. H., Koppen, T., Rüdiger, N., Horn, T. D., Eriksen, J., & Kirman, I. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088746 · Cited by 91
Immune activation genes in inflammatory bowel disease
Matsuura, T., West, G. A., Youngman, K. R., Klein, J. S., & Fiocchi, C. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90413-7 · Cited by 91
Neutrophil-Activating Peptide (Interleukin-8) in Colonic Mucosa from Patients with Crohn's Disease
Izzo, R. S., Witkon, K., Chen, A. I., Hadjiyane, C., Weinstein, M. I., & Pellecchia, C. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309090244 · Cited by 82
Kusugami, K., Youngman, K. R., West, G. A., & Fiocchi, C. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91408-x · Cited by 81
Serum Tumor Necrosis Factor Activity in Inflammatory Bowel Disease
Maeda, M., Watanabe, N., Neda, H., Yamauchi, N., Okamoto, T., Sasaki, H., Tsuji, Y., Akiyama, S., Tsuji, N., & Niitsu, Y. (1992) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979209005404 · Cited by 80
Interleukin 2 Modulates Intestinal Epithelial Cell Functionin Vitro
Dignass, A. U., & Podolsky, D. K. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0193 · Cited by 77
Holtkamp, W., Stollberg, T., & Reis, H. E. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199503000-00010 · Cited by 65
Izutani, R., Loh, E. Y., Reinecker, H., Ohno, Y., Fusunyan, R. D., Lichtenstein, G. R., Rombeau, J. L., & MacDermott, R. P. (1995) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780010106 · Cited by 57
10 Cytokines and inflammatory bowel disease
Radford‐Smith, G. L., & Jewell, D. P. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90045-7 · Cited by 55
Prospective evaluation of interferon-α in treatment of chronic active Crohn's disease
Gasché, C., Reinisch, W., Vogelsang, H., Pötzi, R., Markis, V., Micksche, M., Wirth, H., Gangl, A., & Lochs, H. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064982 · Cited by 50
Andus, T., Targan, S. R., Deem, R. L., & Toyoda, H. (1993) · PubMed · Cited by 29
Self-citationSerum interferon activity in inflammatory bowel disease
Nielsen, O. H., Elmgreen, J., & Ahnfelt-Rønne, I. (1988) · Inflammation · doi:10.1007/bf00916400 · Cited by 10
Cited by
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
The Contribution of Interleukin‐1 and Tumor Necrosis Factor to Periodontal Tissue Destruction
Graves, D. T., & Cochran, D. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.3.391 · Cited by 1,003
Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Metadata
- Authors
- Rogler, G., & Andus, T.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 1998-04
- Volume
- 22
- Issue
- 4
- Pages
- 382-389
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W1966961395
- Cited by
- 484
- References
- 66
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.